Prealbumin/CRP Based Prognostic Score, a New Tool for Predicting Metastasis in Patients with Inoperable Gastric Cancer

Table 3

Comparison between patients with metastatic and nonmetastatic inoperable gastric adenocarcinoma based on indicators of nutritional and inflammatory status.

	Metastatic	Nonmetastatic	Mean difference (95% CI)	value
BMI	21.94 ± 3.94	22.13 ± 4.11	0.18 (−2.43 to 2.81)	0.885
Albumin	3.57 ± 0.74	3.94 ± 0.68	0.36 (−0.30 to 0.76)	0.070
Prealbumin	0.14 ± 0.06	0.20 ± 0.10	0.06 (0.01 to 0.09)	0.012
Transferrin	218.48 ± 119.68	279.07 ± 135.75	60.59 (−5.75 to 126.94)	0.073
CRP	37.60 (15.59–85.16)	15.61 (5.52–30.01)		0.004
TLC	1.18 ± 0.49	1.27 ± 0.54	0.09 (−0.19 to 0.37)	0.516
PG-SGA	17 (13–20.50)	17 (11–19)	0.564	0.564

Mean ± SD, value based on independent-samples -test.
Median (percentiles 25–75), value based on Mann-Whitney test (only value was reported).
Unresectable gastric cancer.